The Annexure

News to 16 October 2026 ·

What the ground filed.

A desk of BSE disclosures — every listed company, sliced the way you need it.

Data as of 16 October 2026

Credit Rating

Please find enclosed rating rationale issued by India Ratings and Research

The filing

Please find enclosed rating rationale issued by India Ratings and Research

Company
Glenmark Pharmaceuticals Ltd · BSE 532296
Filed
11 September 2026, 08:45 IST
BSE category
Company Update / Credit Rating
Tag
Credit Rating · selected
Source
Open the filing on BSE →

Why it led

  • First Credit Rating from this company — not seen in the 98 trading days on record
  • Mid cap · NIFTY 500
  • 2 filings today

Selected by the ranker from 36 filings that day. Each line above is a component of that score, not a comment on the filing.

How often this tag appears

815 of 90,303 filings in the published window carry Credit Rating · 0.9%

Around it

Also filed by Glenmark Pharmaceuticals Ltd on 11 September 2026

Most recent filings from Glenmark Pharmaceuticals Ltd

The company

Glenmark Pharmaceuticals Ltd

BSE 532296 · NSE GLENMARK · ISIN INE935A01035 · Group A · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

Full figures, price and filing history for Glenmark Pharmaceuticals Ltd →